Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
CLOSTRIDIUM PERFRINGENS TYPE A TOXOID CLOSTRIDIUM PERFRINGENS TYP B CLOSTRIDIUM PERFRINGENS TYPE C TOXOID CLOSTRIDIUM PERFRINGENS TYPE D TOXOID CLOSTRIDIUM CHAUVOEI WHOLE CULTURE CLOSTRIDIUM NOVYI TYPE B TOXOID CLOSTRIDIUM SEPTICUM TOXOID CLOSTRIDIUM TETANI TOXOID CLOSTRIDIUM SORDELLII TOXOID CLOSTRIDIUM HAEMOLYTICUM TOXOID (STRAIN CN 3629)
Pfizer Healthcare Ireland
QI02AB01
Suspension for Injection
Immunological - Inactivated vaccine
Bovine
2009-10-23
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Covexin 10 Suspension for injection for sheep and cattle. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION * ELISA According to Ph.Eur. 1 In House ELISA ** Challenge test according to Ph.Eur. # In vitro toxin neutralisation test based on haemolysis of sheep erythrocytes. For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Suspension for injection. Light brown aqueous suspension that settles on storage. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Sheep and cattle. Active ingredients Potency value/mL _C. perfringens _type A toxoid 0.5 U # _C. perfringens _type B & C ( ) toxoid 18.2 IU* _C. perfringens _type D ( ) toxoid 5.3 IU* _C. chauvoei _whole culture meets Ph Eur.** _C. novyi _toxoid 3.8 IU* _C. septicum _toxoid 4.6 IU* _C. tetani _toxoid 4.9 IU* _C_. _sordellii _toxoid 4.4 U 1 _C. haemolyticum _toxoid 17.4 U # _Adjuvant_ Alum 3,026 – 4,094 ppm as aluminium _Preserative_ Thiomersal 0.005-0.018 % w/v Excipient to 1 ml Formaldehyde 0.05% w/v IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 24/01/2012_ _CRN 7009761_ _page number: 1_ 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the active immunisation of sheep and cattle against diseases associated with infections caused by _Clostridium_ _perfringens _type A, _C. perfringens _type B, _C. perfringens _type C, _C. perfringens _type D, _Clostridium chauvoei_, _Clostridium novyi _type B, _Clostridium septicum_, _Clostridium sordellii _and _Clostridium haemolyticum _and against tetanus caused by _Clostridium tetani_. For the passive immunisation of lambs and calves against infections caused by the above mentioned clostridial species (except _C. haemolyticum in sheep)_. Read the complete document